US Patent 7271238 Amylin agonist peptides and uses therefor
Patent 7271238 was granted and assigned to Amylin Pharmaceuticals on September, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+219 characters)
Article
Patent abstract
Agonist analogues of amylin and related pharmaceutical compositions, and methods of treatment of diabetes and other insulin-requiring states, as well as methods of treatment of hypoglycemia, are provided.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07271238 Amylin agonist peptides and uses therefor US Patent 7271238 Amylin agonist peptides and uses therefor
Infobox
Patent Number
0727123800
Patent Number
727123800
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072712380
Date of Patent
September 18, 2007
0Patent Application Number
106491380
Date Filed
August 26, 2003
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072712380
Date of Patent
September 18, 2007
0Patent Application Number
106491380
Date Filed
August 26, 2003
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07271238 Amylin agonist peptides and uses therefor
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07271238
Date of patent
September 18, 2007
Patent application number
10649138
Date Filed
August 26, 2003
Patent primary examiner
Find more entities like US Patent 7271238 Amylin agonist peptides and uses therefor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
